- Fund Type: Open-End Fund
- Objective: Blend - Large Cap
- Asset Class: Equity
- Geographic Focus: Global
Snapshot for DWS Austria - Vermoegensbildungsfonds (D1WA)
| Open: | - | High - Low: | - | Primary Exchange: | Tradegate |
|---|---|---|---|---|---|
| Volume: | 0 | 52-Week Range: | - | Beta vs MSERWI: | - |
Fund Profile & Information for D1WA
DWS (Austria) Vermoegensbildungsfonds is an open-end investment fund incorporated in Austria. The Fund's objective is to achieve high returns. The Fund invests primarily in international stocks.
| Inception Date: | 2001-07-23 | Telephone: | +43 (0) 50100-0 |
|---|---|---|---|
| Managers: | CHRISTOPH-AREND SCHMIDT | ||
| Web Site: | www.erste-am.at | ||
Fundamentals for D1WA
| NAV | - |
|---|---|
| Assets (M) | (on 2013-06-19) 31.5996 |
| Shares out (M) | 0.00 |
| Market Cap (M) | 0.00 |
| % Premium | - |
| Average 52-Week % Premium | - |
| Fund Leveraged | N |
Dividends for D1WA
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Annual |
| Last Dividend Net | (on 2013-01-31) 0.0400 |
| Dividend Yield (ttm) | 0.08% |
Performance for D1WA
| 1-Month | - | 1-Year | - |
|---|---|---|---|
| 3-Month | - | 3-Year | - |
| Year To Date | - | 5-Year | - |
| Expense Ratio | - |
Top Fund Holdings for D1WA
Filing Date: 12/28/2012| Name | Position | Value | % of Total |
|---|---|---|---|
| Super Group Ltd/Singapore | 350,000 | 677,967 | 2.185% |
| Sanofi | 9,000 | 649,350 | 2.093% |
| Apple Inc | 1,515 | 590,142 | 1.902% |
| Pfizer Inc | 29,700 | 564,687 | 1.820% |
| JPMorgan Chase & Co | 16,000 | 527,949 | 1.701% |
| Koninklijke DSM NV | 11,250 | 515,925 | 1.663% |
| China Mobile Ltd | 57,000 | 500,241 | 1.612% |
| Reckitt Benckiser Group PLC | 10,500 | 498,843 | 1.608% |
| Roche Holding AG | 3,200 | 491,701 | 1.585% |
| Safran SA | 14,800 | 480,334 | 1.548% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page